Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial

Dig Dis Sci. 1999 Jun;44(6):1220-1. doi: 10.1023/a:1026648812439.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Colitis, Ulcerative / drug therapy*
  • Colitis, Ulcerative / metabolism
  • Double-Blind Method
  • Gastrointestinal Agents / pharmacokinetics
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Pilot Projects
  • Placebos
  • Rifamycins / pharmacokinetics
  • Rifamycins / therapeutic use*
  • Rifaximin

Substances

  • Gastrointestinal Agents
  • Placebos
  • Rifamycins
  • Rifaximin